Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02117362
Brief Title: Galectin Inhibitor (GR-MD-02) and Ipilimumab in Patients With Metastatic Melanoma

First Submitted : April 14, 2014
First Submitted that Met QC Criteria : April 15, 2014
First Posted : April 17, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : March 19, 2019
Last Update Posted : March 21, 2019